Page 231 - Read Online
P. 231

Singh et al.                                                                                                                                                         Myocardial protection in cardiac transplantation

           of  loading  conditions,  endothelial  dysfunction  and   to  the  control  group  and  the  all-cause  mortality  was
           impairment of coronary blood flow [126] .          assessed over 1.54 (SD 1.22) years and was lower with
                                                              remote ischaemic preconditioning than without (ratio
           Nicolas-Robin  et  al. [127]   looked  at  GKI  infusion  in   0.27, 95% CI 0.08-0.98, P = 0.046) [137] . Hong et al. [140]
           comparison to dobutamine for in DBD donors. They   however failed to demonstrate any difference between
           found  that  a  GKI  infusion  significantly  improved  the   the groups but it should be noted that he included RIC
           systolic dysfunction comparably to dobutamine without   with PostC in 1280 patients and had a much broader
           its  inherent  side  effects  of  peripheral  vasodilation,   composite  of  outcomes.  Hong’s  group  also  failed  to
           potential arrhythmogenesis, and tachycardia. This was   record any biomarkers, limiting the end-points to solely
           thought to be possibly due to an adaptive hibernating   clinical outcomes.
           state of the myocardium to reduce myocardial oxygen
           demand, thereby allowing a longer period of ischaemia   Sachdeva et al. [141]  noted no subsequent benefit in both
           without necrosis [128] . Hence the rationale behind GKI   remote  preconditioning  and  postconditioning  alone
           infusion is  by  replenishing  the energy  supply  of  the   or  in  combination  and  observed  that  they  failed  to
           failing heart, by switching metabolism from oxidation   attenuate infarct size in an anesthetized rat model with
           of fatty acids (glycogenolysis) to oxidation of glucose   myocardial infarction. There was also no recovery of
           (glycolysis) and lactate [129] . This allows restoration of   LV dysfunction induced by ischemia-reperfusion injury.
           calcium homeostasis and replenishment of glycogen
           stores by increasing the rate of ATP [130] . Although GKI   However,  the  recently  concluded  randomized
           was not shown to improve mortality in acute myocardial   LipsiaConditioning [142]  trial studied the effects of RIC
           infarction as mentioned above, there may be a role for   and PostC revealed conflicting evidence to this. Using
           it in the ischaemic myocardium.                    cardiac  magnetic  resonance  to  quantify  myocardial
                                                              injury, they showed that combined intra-hospital RIC
           Cottin et al. [131]  demonstrated that their cohort of patients   and PostC significantly increases myocardial salvage
           with heart failure (Ejection Fraction < 45%), GKI infusion   when compared with conventional PCI, whereas PostC
           reduced  Wall  Motion  Score  Index  and  increased   alone failed to demonstrate a cardioprotective effect in
           ejection fraction significantly in their small study. Similar   STEMI patients undergoing primary PCI.
           findings were noted in several other studies, including a
           reduction in BNP concentrations [132-135] .        Another article by Pichot  et  al. [143]  however revealed

                                                              PostC had a significant effect in reducing myocardial
           ISCHAEMIC CONDITIONING                             injury independently of traditional cardiovascular risk
                                                              factors in patients with STEMI.
           Reperfusion injury is postulated to be a key
           contributing factor for primary graft dysfunction, thus   Ischaemic conditioning has garnered a lot of interest in
           the role of ischaemic conditioning whilst still in its   recent times with almost 500 articles published every
           trialling phase may be of benefit. The lack of evidence   year,  and 53 clinical trials  (phase I  to  IV)  available
           of benefit in large scale studies such as RIPheart [136]    on  PubMed.  Of  these  37  clinical  trials  are  specific
           and ERICCA  [137]  clarified that this intervention does not   to cardiac surgery alone [144] . A lot of the RIC data in
           confer any benefits to patients undergoing CABG.   other studies have focused on biomarkers of cardiac
                                                              injury and not outcomes, which were the endpoints for
           Animal  models  have  shown  potential  benefits  and   both RIPheart and ERICCA. To date, no adequately
           cardioprotective mechanisms,  but  while biochemical   powered and randomised trial has looked at the effect
           improvements  were noted by the ERICCA  trial      of  RIC and PostC in transplantation,  and given the
           (reduced troponin levels), its relevance remains to be   recent findings of large trials in CABGs, an adequately
           seen. Remote ischaemic preconditioning (RIC) and   powered  trial  in  transplant  cannot  be  justified.  The
           remote ischaemic post conditioning (PostC) work    negative results have generated more discussion and
           on the premise that brief episodes of ischemia and   questions with better discourse into methodology. For
           reperfusion to the remote organ protect the heart by   example, in Kottenberg et al. [145] ’s study, propofol was
           a paracrine or neural-reflex mechanism while avoiding   a potential confounding factor. Propofol interferes with
           additional stress on the heart itself [138] .      the activation of the signal transducer and activator
                                                              of transcription 5 (STAT5) pathway. A recent study
           Thielmann et al. [139]  conducted the first single centre   by Kleinbongard et al. [146]  looking at confounders that
           randomised, double blind controlled trial of RIC in 329   may  affect  the  efficacy  of  RIC  found  that  patients
           patients  from  2008-2012.  They  found  a  significantly   with an aortic cross-clamp time of < 56 min had no
           lower troponin level (cTnI) in the RIC group compared   protection by RIC whereas there was solid protection

            224                                                                                                                    Vessel Plus ¦ Volume 1 ¦ December 28, 2017
   226   227   228   229   230   231   232   233   234   235   236